Caleb Chandler
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Caleb Chandler has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Alan Sellinger
Colorado School of Mines
4 shared publications - Daniel D. Astridge
Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, 12850 East Montview Boulevard, Aurora, Colorado 80045, United States
2 shared publications - Dominique H. Porcincula
Lawrence Livermore National Laboratory Livermore CA 94550 USA
2 shared publications - Jason Brodsky
Lawrence Livermore National Laboratory
2 shared publications - Jason P. Killgore
Applied Chemicals and Materials Division, National Institute of Standards and Technology, Boulder, USA
2 shared publications Jonathan Arrue
Nuclear and Radiological Engineering and Medical Physics Program, George W. Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, GA, USA
2 shared publications
Latest Publications
- Open Access
- 9 April 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (15)
Metabolite mimicry identifies butyrate analogs with select protective functions in the intestinal mucosa
Microbial-derived short-chain fatty acids regulate a variety of pathways in the healthy colonic mucosa. In particular, butyrate serves as the primary energy source for colonocytes and regulates gene transcription by stabilizing the transcription factor hypoxia-inducible-factors (HIF) and functioning as a histone deacetylase (HDAC) inhibitor. A limitation of butyrate as a therapeutic is its rapid metabolism in differentiated colonocytes. Furthermore, intestinal stem cells (ISCs) respond differently to butyrate, preferentially using glucose for energy procurement. To address these limitations, we explored metabolite mimicry to identify compounds with potent or selective biological responses within the butyrate pathway(s). We found an analog, 3-chlorobutyrate (3-Cl BA), that significantly enhances epithelial barrier formation and wound healing in vitro. Mechanistically, we revealed that 3-Cl BA is a potent HDAC inhibitor. Furthermore, unlike butyrate, 3-Cl BA does not stabilize HIF and it is not used as metabolic fuel. In vivo studies in a dextran sulfate sodium-colitis model revealed that contrary to butyrate, 3-Cl BA is protective. Studies in stem-like colonoids demonstrated that only butyrate inhibits ISC proliferation and differentiation. Furthermore, it was recently reported that HIF stabilization inhibits ISCs activity. Given the fact that butyrate but not 3-Cl BA stabilizes HIF, we surmised that 3-Cl BA would circumvent these detrimental functional consequences. We demonstrate here that pharmacologic HIF stabilization inhibits colonoid differentiation and that genetic loss of HIF significantly promotes ISC differentiation. This study reveals a promising butyrate analog protective in colitis and demonstrates the advantages of metabolite mimicry to dissect selective biological functions from major metabolites in the gut.
- 9 April 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (15)
Open AccessMetabolite mimicry identifies butyrate analogs with select protective functions in the intestinal mucosa
Microbial-derived short-chain fatty acids regulate a variety of pathways in the healthy colonic mucosa. In particular, butyrate serves as the primary energy source for colonocytes and regulates gene transcription by stabilizing the transcription factor hypoxia-inducible-factors (HIF) and functioning as a histone deacetylase (HDAC) inhibitor. A limitation of butyrate as a therapeutic is its rapid metabolism in differentiated colonocytes. Furthermore, intestinal stem cells (ISCs) respond differently to butyrate, preferentially using glucose for energy procurement. To address these limitations, we explored metabolite mimicry to identify compounds with potent or selective biological responses within the butyrate pathway(s). We found an analog, 3-chlorobutyrate (3-Cl BA), that significantly enhances epithelial barrier formation and wound healing in vitro. Mechanistically, we revealed that 3-Cl BA is a potent HDAC inhibitor. Furthermore, unlike butyrate, 3-Cl BA does not stabilize HIF and it is not used as metabolic fuel. In vivo studies in a dextran sulfate sodium-colitis model revealed that contrary to butyrate, 3-Cl BA is protective. Studies in stem-like colonoids demonstrated that only butyrate inhibits ISC proliferation and differentiation. Furthermore, it was recently reported that HIF stabilization inhibits ISCs activity. Given the fact that butyrate but not 3-Cl BA stabilizes HIF, we surmised that 3-Cl BA would circumvent these detrimental functional consequences. We demonstrate here that pharmacologic HIF stabilization inhibits colonoid differentiation and that genetic loss of HIF significantly promotes ISC differentiation. This study reveals a promising butyrate analog protective in colitis and demonstrates the advantages of metabolite mimicry to dissect selective biological functions from major metabolites in the gut.
- Open Access
- 22 November 2025
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 17 (1) , 370-384
The structural requirements of 3,5-substituted oxindoles that determine selective AMPK or GSK3β inhibition
Structural requirements for oxindole-based AMPK inhibitors with the 5-(2-cyanoethyl)- and the 3-substituent as the Z -isomer form providing selectivity for AMPK over GSK3β.
- 22 November 2025
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 17 (1) , 370-384
Open AccessThe structural requirements of 3,5-substituted oxindoles that determine selective AMPK or GSK3β inhibition
Structural requirements for oxindole-based AMPK inhibitors with the 5-(2-cyanoethyl)- and the 3-substituent as the Z -isomer form providing selectivity for AMPK over GSK3β.
- Open Access
- 12 August 2025
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 65 (16) , 8411-8425
RiSKs in Computational Modeling of Isoform-Selective RSK Inhibitors
Recent developments around inhibitors of the 90 kDa ribosomal S6 serine/threonine kinases (RSK1–4) have been focused on the optimization of known pan-RSK inhibitors such as SL0101 and BI-D1870. The RSKs are an intriguing target for cancer therapy due to their role as downstream effectors in the MAPK pathway. Herein, we focus on the utilization of computational modeling in inhibitor screening and development for RSK, and we examine computational artifacts in molecular modeling, quantum mechanical calculations, molecular dynamics, and high throughput screening. Variation between RSK structural models is also evident, given the available crystal structures, and liberties in homology modeling and dynamic conformations may capture new targeting approaches for these proteins. Furthermore, pan-kinase inhibitors are often used to target RSK since the four different RSK isoforms share a high degree of homology; however, they have distinct biological actions in cancer. A majority of RSK modeling generalizes the conclusions from one isoform onto the others; therefore, forming accurate isoform specific models containing their subtle differences will be key to the development of isoform-selective inhibitors. This review consolidates existing RSK models and the isoform specific structural differences that have and have not been considered, evaluates inhibition studies that have started to build upon RSK selectivity, including for its isoforms, and assesses other inhibitory binding sites to offer potential pathways forward. The leveraging of these differences through computational methods aims to guide next-generation isoform-selective RSK inhibitors.
- 12 August 2025
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 65 (16) , 8411-8425
Open AccessRiSKs in Computational Modeling of Isoform-Selective RSK Inhibitors
Recent developments around inhibitors of the 90 kDa ribosomal S6 serine/threonine kinases (RSK1–4) have been focused on the optimization of known pan-RSK inhibitors such as SL0101 and BI-D1870. The RSKs are an intriguing target for cancer therapy due to their role as downstream effectors in the MAPK pathway. Herein, we focus on the utilization of computational modeling in inhibitor screening and development for RSK, and we examine computational artifacts in molecular modeling, quantum mechanical calculations, molecular dynamics, and high throughput screening. Variation between RSK structural models is also evident, given the available crystal structures, and liberties in homology modeling and dynamic conformations may capture new targeting approaches for these proteins. Furthermore, pan-kinase inhibitors are often used to target RSK since the four different RSK isoforms share a high degree of homology; however, they have distinct biological actions in cancer. A majority of RSK modeling generalizes the conclusions from one isoform onto the others; therefore, forming accurate isoform specific models containing their subtle differences will be key to the development of isoform-selective inhibitors. This review consolidates existing RSK models and the isoform specific structural differences that have and have not been considered, evaluates inhibition studies that have started to build upon RSK selectivity, including for its isoforms, and assesses other inhibitory binding sites to offer potential pathways forward. The leveraging of these differences through computational methods aims to guide next-generation isoform-selective RSK inhibitors.
- 9 September 2024
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Nuclear Science
- Vol. 71 (11) , 2449-2456
Boron-10-Doped Polysiloxanes as Matrix Materials for Application in the Simultaneous Detection and Discrimination of Gamma Rays and Fast and Thermal Neutrons
Three boron-10 enriched aromatic molecules have been synthesized and incorporated into two different commercial polysiloxane resins, Shin Etsu KER-6000 and Wacker SilRes H62-C. Scintillating fluorophores, 9,9-dimethyl-2-phenylfluorene (PhF) and 2,5-diphenyloxazole (PPO), were tested in combination with each resin and boron-10 molecule for the simultaneous detection of gamma rays, fast neutrons, and thermal neutrons. The H62-C resin was able to solubilize a large amount of PhF, in excess of 20 wt%. Cure kinetics were controlled through the addition of divinylbenzene and phenyl tris(dimethylsiloxy)silane cross-linker solution to the H62-C resin, with rheology experiments demonstrating a large reduction in time to gelation when 20 wt% cross-linker solution was added, from more than 4 hours to less than 1 hour. These polysiloxane resins can be cured in 3 hours under air, while common poly(vinyltoluene) scintillators require at least 4 days of heating and oxygen-free conditions. PhF-doped KER-6000 with tolyl boronate pinacol ester exhibited the best overall performance with a light yield of 62% relative to EJ-200 and thermal neutron capture at energies up to 103 keVee (84 keVee for EJ254B-5). Additionally, four samples exhibited light yields surpassing an industry-standard boron-doped plastic scintillator, Eljen’s EJ254B-5. Over the course of ten months, the KER-6000 samples showed precipitation of dopant molecules, which reduced their light yield by 15% on average, while H62-C proved to be more stable with only a 6% reduction.
- 9 September 2024
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Nuclear Science
- Vol. 71 (11) , 2449-2456
Boron-10-Doped Polysiloxanes as Matrix Materials for Application in the Simultaneous Detection and Discrimination of Gamma Rays and Fast and Thermal Neutrons
Three boron-10 enriched aromatic molecules have been synthesized and incorporated into two different commercial polysiloxane resins, Shin Etsu KER-6000 and Wacker SilRes H62-C. Scintillating fluorophores, 9,9-dimethyl-2-phenylfluorene (PhF) and 2,5-diphenyloxazole (PPO), were tested in combination with each resin and boron-10 molecule for the simultaneous detection of gamma rays, fast neutrons, and thermal neutrons. The H62-C resin was able to solubilize a large amount of PhF, in excess of 20 wt%. Cure kinetics were controlled through the addition of divinylbenzene and phenyl tris(dimethylsiloxy)silane cross-linker solution to the H62-C resin, with rheology experiments demonstrating a large reduction in time to gelation when 20 wt% cross-linker solution was added, from more than 4 hours to less than 1 hour. These polysiloxane resins can be cured in 3 hours under air, while common poly(vinyltoluene) scintillators require at least 4 days of heating and oxygen-free conditions. PhF-doped KER-6000 with tolyl boronate pinacol ester exhibited the best overall performance with a light yield of 62% relative to EJ-200 and thermal neutron capture at energies up to 103 keVee (84 keVee for EJ254B-5). Additionally, four samples exhibited light yields surpassing an industry-standard boron-doped plastic scintillator, Eljen’s EJ254B-5. Over the course of ten months, the KER-6000 samples showed precipitation of dopant molecules, which reduced their light yield by 15% on average, while H62-C proved to be more stable with only a 6% reduction.
- 14 June 2024
- Published by American Chemical Society (ACS) in ACS Applied Polymer Materials
- Vol. 6 (12) , 6957-6965
Tailoring Properties of 3D-Printable Polyelectrolyte Photopolymer Complexes with Reactive Diluents
- 14 June 2024
- Published by American Chemical Society (ACS) in ACS Applied Polymer Materials
- Vol. 6 (12) , 6957-6965
Tailoring Properties of 3D-Printable Polyelectrolyte Photopolymer Complexes with Reactive Diluents
- 1 September 2023
- Published by Elsevier in Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment
- Vol. 1056
Impact of temperature on light yield and pulse shape discrimination of polysiloxane-based organic scintillators formulated with commercial resins
- 1 September 2023
- Published by Elsevier in Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment
- Vol. 1056
Impact of temperature on light yield and pulse shape discrimination of polysiloxane-based organic scintillators formulated with commercial resins
- 16 May 2022
- Published by American Chemical Society (ACS) in ACS Applied Polymer Materials
- Vol. 4 (6) , 4069-4074
Plastic Scintillators via Rapid Photoinitiated Cationic Polymerization of Vinyltoluene
- 16 May 2022
- Published by American Chemical Society (ACS) in ACS Applied Polymer Materials
- Vol. 4 (6) , 4069-4074
Plastic Scintillators via Rapid Photoinitiated Cationic Polymerization of Vinyltoluene